Pharma BD Deal Intelligence
Labcorp agreed to acquire select laboratory testing assets of BioReference Health, a wholly owned subsidiary of OPKO Health, for $722 million in cash at closing (subject to adjustment based on closing business revenues) plus up to $150 million in an earnout tied to 4Kscore Test revenue, for total potential consideration of $872 million. The acquired perimeter covers BioReference's clinical and women's health testing, urology and corrections testing businesses, more than 80 additional patient service centers, and the FDA-approved 4Kscore Test. Labcorp expects the acquired business to contribute approximately $250 million of revenue in the first year after closing. The transaction is subject to regulatory approvals and customary closing conditions. NOTE: ingested at pending_review by bd-enrichment 2026-10-19.
← Browse all deals · How we score deals
More: 2026 deals